Explore more about your Alpha-1 journey
ZEMAIRA has been proven to raise and maintain serum levels of A1AT protein.13
When administered once a week for 24 weeks at a dose of 60 mg per kg of body weight, patients with Alpha-1 saw a rapid increase in A1AT levels that were maintained throughout the study period.13
Clinical data demonstrating the long-term effects of chronic augmentation therapy with ZEMAIRA are not available.
ZEMAIRA is made in a state-of-the-art facility under strict, controlled conditions, and is purified from human plasma through a rigorous virus-removal and inactivation process. Because ZEMAIRA is made from human blood, the risk of transmitting infectious agents cannot be completely eliminated.
Studies have shown that A1AT augmentation therapy is safe.
In clinical studies of ZEMAIRA, at least 5% of subjects reported adverse reactions related to treatment, including:
Enroll online or call ZEMAIRA CareZ® to speak with an experienced CareZ Care Coordinator. Call 1-866-ZEMAIRA (1-866-936-2472) and learn more.